By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Array BioPharma, Inc. 

3200 Walnut Street

Boulder  Colorado  80301  U.S.A.
Phone: 303-381-6600 Fax: 303-381-6697


Drug Discovery

Company News
Array BioPharma (ARRY) Announces Clinical Data Presentation On ARRY-797 At The 2016 European Society of Cardiology Congress 8/22/2016 7:59:45 AM
Array BioPharma (ARRY) Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2016 8/4/2016 9:47:24 AM
Array BioPharma (ARRY) To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2016 On August 4, 2016 7/28/2016 8:51:02 AM
Array BioPharma (ARRY) Announces Appointment Of Jason Haddock As Chief Financial Officer 7/28/2016 6:47:12 AM
Array BioPharma (ARRY) To Present At The Cantor Fitzgerald 2nd Annual Healthcare Conference 7/8/2016 8:41:24 AM
Array BioPharma (ARRY) Submits Binimetinib New Drug Application To U.S. FDA 7/1/2016 6:25:17 AM
ASCO2016: Array BioPharma (ARRY) Presents Full Results From Phase 3 NEMO Study 6/7/2016 7:50:28 AM
Array BioPharma (ARRY), Pierre Fabre And Merck KGaA (MKGAF.PK), Darmstadt, Germany Announce Phase 3 BEACON CRC Trial 6/6/2016 10:58:54 AM
Array BioPharma (ARRY) Release: Encorafenib-Based Regimens Provide Improved PFS And OS In Difficult-To-Treat BRAF-Mutant Colorectal Cancer Compared To Historical Benchmarks 6/6/2016 10:11:45 AM
Merck & Co. (MRK) Partners With Array BioPharma (ARRY) And Pierre Fabre To Initiate BRAF-Mutant CRC Phase III Trial 6/6/2016 9:59:43 AM